Related Experiment Video
Updated: Jan 22, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Lifestyle factors and cardiometabolic risk
Weiqin Li1, Yun Shen2, Gang Hu2
1Tianjin Women's and Children's Health Center, Tianjin 300070, China.
Insights
Adhering to the American Heart Association's Life's Essential 8 (LE8) guidelines, covering diet, exercise, and other factors, significantly lowers risks for cardiovascular disease and type 2 diabetes. Promoting these healthy lifestyle behaviors is crucial for reducing global cardiometabolic risk.
Area of Science:
- Cardiology
- Metabolic Health
- Public Health
Background:
- Cardiometabolic risk, including cardiovascular diseases (CVDs) and type 2 diabetes (T2D), poses a significant global health challenge.
- The American Heart Association's "Life's Essential 8" (LE8) framework outlines eight key factors for optimizing cardiovascular health.
Purpose of the Study:
- To review the associations between individual and combined lifestyle factors and cardiometabolic risk.
- To examine the impact of LE8 principles on the development and progression of CVD and T2D.
Main Methods:
- Literature review analyzing studies on lifestyle factors and cardiometabolic risk.
- Focus on CVD and T2D as representative cardiometabolic conditions.
Main Results:
- Adherence to healthy lifestyle behaviors (diet, physical activity, no smoking, healthy weight) significantly reduces risks of CVD, T2D, and hypertension.
- Following 3-4 LE8 factors lowers the risk of diabetes transition, complications, and mortality.
Conclusions:
- Promoting LE8 principles is vital for reducing the global burden of cardiometabolic risk.
- Overcoming barriers to healthy lifestyles requires innovative public health and personalized interventions.
Abstract:
Cardiometabolic risk encompasses the interconnected conditions of cardiovascular diseases (CVDs), type 2 diabetes (T2D), and other metabolic diseases, which are leading global health challenges. The American Heart Association (AHA) has introduced "Life's Essential 8" (LE8), a framework emphasizing eight key lifestyle and health factors, including diet, physical activity, smoking, sleep health, body weight, blood glucose, blood lipids, and blood pressure to optimize cardiovascular health and reduce the burden of cardiometabolic risk. This review examined the associations between individual and combined lifestyle factors and the development and progression of cardiometabolic risk, using CVD and T2D as representative conditions. Evidence highlighted that adherence to healthy lifestyle behaviors, such as maintaining a balanced diet, engaging in physical activity, avoiding smoking, and achieving a healthy weight, significantly reduced the risks of CVD, T2D, and hypertension. Studies showed that adherence to 3-4 healthy lifestyle factors lowers the risk of transition from baseline to diabetes, complications, and mortality. Despite the proven benefits, barriers such as limited access to healthy food and safe environments for physical activity hinder widespread adoption. Addressing these challenges requires innovative public health interventions and personalized strategies targeting high-risk populations. This review underscored the importance of promoting and adhering to LE8 principles to reduce the global burden of cardiometabolic risk and improve overall health outcomes.
Related Concept Videos
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Introduction to Stress and Lifestyle
Hypertension IV: Drug Therapy and Lifestyle Modifications
Relative Risk
Transcription Factors

